Purchase Order 75D30118P03277
Award Date 9/17/18
Potential Completion Date 9/16/19
Potential Value $150K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qoolabs Inc., a self-certified small disadvantaged and woman-owned business. The $150,000 contract is for critical functions, with a period of performance ending on March 20, 2017. Qoolabs Inc. is a biotech company that has received over $4 million in prime federal contracts from the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH),...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase 1 contract to Lynntech Inc., a small business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis-associated epilepsy. The firm fixed-price contract has a potential value of $149,875 and was awarded on September 17, 2018, with a completion date of September 16, 2019. The contract was set aside for small businesses.
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract for $299,991.00 to Qoolabs Inc., a self-certified small disadvantaged business. The contract is for the development of point-of-care diagnostics for the detection of the liver flukes Opisthorchis viverrini and Clonorchis sinensis, under Topic 388. The work will be performed by Qoolabs Inc. in San Diego, California. Qoolabs Inc....
- This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...
- This is a $1,500,000.00 SBIR Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qoolabs Inc., a small disadvantaged and woman-owned business located in Carlsbad, California. The contract is for research and development of medical technologies related to infectious diseases, immunology, and COVID-19 detection, including the development of affinity reagents,...
- This is a Small Business Innovation Research (SBIR) Phase 1 contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Kephera Diagnostics LLC, a small business. The contract is for the development of diagnostics to detect taeniasis, a parasitic infection, in order to prevent neurocysticercosis and associated epilepsy. The award amount is $150,000.00 and the contract has a firm fixed price pricing type. The contract was set aside...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to develop rapid point-of-care detection tests for serologic status of individuals for cytomegalovirus (CMV) and herpes simplex virus (HSV) infections. The $225,000.00 fixed-price contract has a period of performance through July 31, 2018,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
- This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This...